Clinical Trial Update: Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study [Phase 3]

View source ↗

Summary

Pilot Phase 3 trial investigating melatonin with acid inhibition for chemoprevention in Barrett's Esophagus; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Aragon Institute of Health Sciences | Conditions: Barrett's Esophagus | Phase 3 | Status: COMPLETED